What do systematic reviews say?

Duodenum‐preserving pancreatic resection vs pancreaticoduodenectomy

• Duodenum‐preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis 2016 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 101 participants
  Low

Helicopter emergency medical services vs ground emergency medical services

The review found no eligible studies for this question.

• Helicopter emergency medical services for adults with major trauma 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Cognitive stimulation vs no cognitive stimulation (post‐treatment)

• Cognitive stimulation to improve cognitive functioning in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  18 studies · 1584 participants
  Moderate

Group cognitive stimulation vs no cognitive stimulation (post‐treatment)

• Cognitive stimulation to improve cognitive functioning in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  13 studies · 1058 participants
  Low

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ dual therapy: tezacaftor plus ivacaftor vs placebo or ivacaftor alone

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ triple therapy: VX‐659‐tezacaftor‐ivacaftor/deutivacaftor vs control

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ triple therapy: elexacaftor‐tezacaftor‐ivacaftor/deutivacaftor vs control

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ triple therapy: elexacaftor‐tezacaftor‐ivacaftor vs control (ivacaftor alone or tezacaftor plus ivacaftor)

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ triple therapy: VX‐440‐tezacaftor‐ivacaftor vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ triple therapy: VX‐152‐tezacaftor‐ivacaftor vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings ‐ monotherapy: cavosonstat vs placebo

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Trunk training following stroke 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 111 participants
  Very low

Intervention not reported

• Trunk training following stroke 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 108 participants
  Very low

Intervention vs active comparison

The review found no eligible studies for this question.

• Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Magnetic seizure therapy for treatment‐resistant depression 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 20 participants
  Very low

Adverse event outcomes for dietary combined with physical activity interventions vs information only

The review found no eligible studies for this question.

• Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Aerobic exercise and strength training vs usual care

• Physical exercise training for type 3 spinal muscular atrophy 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 12 participants
  Very low

Intervention not reported

• Computerised cognitive training for preventing dementia in people with mild cognitive impairment 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 19 participants
  Low

Pelvic floor muscle training (PFMT) with urotherapy vs urotherapy alone

The review found no eligible studies for this question.

• Conservative interventions for treating functional daytime urinary incontinence in children 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found